134 studies found for:    "Anal cancer"
Show Display Options
Rank Status Study
21 Completed
Has Results
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
Condition: Anal Cancer
Interventions: Drug: Capecitabine;   Drug: Oxaliplatin;   Radiation: Radiation Therapy (XRT)
22 Unknown  Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
Condition: Anal Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
23 Recruiting International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly Paclitaxel
Condition: Squamous Cell Carcinoma of the Anus
Interventions: Drug: Cisplatin;   Drug: 5-Fluorouracil (5-FU);   Drug: Carboplatin;   Drug: Paclitaxel
24 Completed SGN-00101 in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia
Condition: Anal Cancer
Intervention: Biological: HspE7
25 Completed Infrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia
Conditions: Anal Cancer;   Precancerous Condition
Interventions: Procedure: infrared photocoagulation therapy;   Device: Infrared Coagulator
26 Terminated Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer
Condition: Anal Cancer
Interventions: Drug: Tempol;   Drug: 5-Fluorouracil;   Drug: Mitomycin-C;   Procedure: Radiation Therapy
27 Active, not recruiting Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia
Conditions: Anal Cancer;   Neoplasm of Uncertain Malignant Potential;   Nonneoplastic Condition;   Precancerous Condition
Interventions: Other: clinical observation;   Procedure: infrared photocoagulation therapy
28 Unknown  Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer
Conditions: Anal Cancer;   Bladder Cancer;   Cervical Cancer;   Colorectal Cancer;   Fallopian Tube Cancer;   Gastrointestinal Complications;   Ovarian Cancer;   Radiation Toxicity;   Sarcoma
Interventions: Dietary Supplement: dietary intervention;   Other: laboratory biomarker analysis;   Procedure: gastrointestinal complications management/prevention;   Procedure: management of therapy complications;   Radiation: selective external radiation therapy
29 Unknown  Molecular Genetic and Pathological Studies of Anal Tumors
Conditions: Rectal Cancer;   Colon Cancer;   Colonic Neoplasms;   Anal Cancer
Intervention: Other: genetic analysis
30 Not yet recruiting Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients
Conditions: Anus Neoplasms;   Carcinoma, Squamous Cell;   Anus Diseases;   Neoplasms;   Neoplasms, Squamous Cell;   Carcinoma
Interventions: Drug: Paclitaxel;   Drug: Capecitabine;   Drug: Mitomycins;   Radiation: Radiotherapy
31 Completed Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
Conditions: Advanced Adult Primary Liver Cancer;   Anaplastic Thyroid Cancer;   Bone Metastases;   Carcinoma of the Appendix;   Distal Urethral Cancer;   Fallopian Tube Cancer;   Gastrinoma;   Glucagonoma;   Inflammatory Breast Cancer;   Insulinoma;   Liver Metastases;   Localized Unresectable Adult Primary Liver Cancer;   Lung Metastases;   Male Breast Cancer;   Malignant Pericardial Effusion;   Malignant Pleural Effusion;   Metastatic Gastrointestinal Carcinoid Tumor;   Metastatic Parathyroid Cancer;   Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter;   Newly Diagnosed Carcinoma of Unknown Primary;   Occult Non-small Cell Lung Cancer;   Pancreatic Polypeptide Tumor;   Primary Peritoneal Cavity Cancer;   Proximal Urethral Cancer;   Pulmonary Carcinoid Tumor;   Recurrent Adenoid Cystic Carcinoma of the Oral Cavity;   Recurrent Adrenocortical Carcinoma;   Recurrent Adult Primary Liver Cancer;   Recurrent Anal Cancer;   Recurrent Bladder Cancer;   Recurrent Breast Cancer;   Recurrent Carcinoma of Unknown Primary;   Recurrent Cervical Cancer;   Recurrent Colon Cancer;   Recurrent Endometrial Carcinoma;   Recurrent Esophageal Cancer;   Recurrent Extrahepatic Bile Duct Cancer;   Recurrent Gallbladder Cancer;   Recurrent Gastric Cancer;   Recurrent Gastrointestinal Carcinoid Tumor;   Recurrent Islet Cell Carcinoma;   Recurrent Malignant Testicular Germ Cell Tumor;   Recurrent Mucoepidermoid Carcinoma of the Oral Cavity;   Recurrent Non-small Cell Lung Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Pancreatic Cancer;   Recurrent Parathyroid Cancer;   Recurrent Prostate Cancer;   Recurrent Rectal Cancer;   Recurrent Renal Cell Cancer;   Recurrent Salivary Gland Cancer;   Recurrent Small Intestine Cancer;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Nasopharynx;   Recurrent Squamous Cell Carcinoma of the Oropharynx;   Recurrent Thyroid Cancer;   Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter;   Recurrent Urethral Cancer;   Recurrent Vaginal Cancer;   Recurrent Vulvar Cancer;   Skin Metastases;   Small Intestine Adenocarcinoma;   Somatostatinoma;   Stage III Adenoid Cystic Carcinoma of the Oral Cavity;   Stage III Adrenocortical Carcinoma;   Stage III Bladder Cancer;   Stage III Cervical Cancer;   Stage III Colon Cancer;   Stage III Endometrial Carcinoma;   Stage III Esophageal Cancer;   Stage III Follicular Thyroid Cancer;   Stage III Gastric Cancer;   Stage III Malignant Testicular Germ Cell Tumor;   Stage III Mucoepidermoid Carcinoma of the Oral Cavity;   Stage III Ovarian Epithelial Cancer;   Stage III Pancreatic Cancer;   Stage III Papillary Thyroid Cancer;   Stage III Prostate Cancer;   Stage III Rectal Cancer;   Stage III Renal Cell Cancer;   Stage III Salivary Gland Cancer;   Stage III Squamous Cell Carcinoma of the Larynx;   Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage III Squamous Cell Carcinoma of the Nasopharynx;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage III Vaginal Cancer;   Stage III Vulvar Cancer;   Stage IIIA Anal Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Anal Cancer;   Stage IIIB Breast Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Adenoid Cystic Carcinoma of the Oral Cavity;   Stage IV Adrenocortical Carcinoma;   Stage IV Anal Cancer;   Stage IV Bladder Cancer;   Stage IV Breast Cancer;   Stage IV Colon Cancer;   Stage IV Endometrial Carcinoma;   Stage IV Esophageal Cancer;   Stage IV Follicular Thyroid Cancer;   Stage IV Gastric Cancer;   Stage IV Mucoepidermoid Carcinoma of the Oral Cavity;   Stage IV Non-small Cell Lung Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Pancreatic Cancer;   Stage IV Papillary Thyroid Cancer;   Stage IV Prostate Cancer;   Stage IV Rectal Cancer;   Stage IV Renal Cell Cancer;   Stage IV Salivary Gland Cancer;   Stage IV Squamous Cell Carcinoma of the Larynx;   Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Cervical Cancer;   Stage IVA Vaginal Cancer;   Stage IVB Cervical Cancer;   Stage IVB Vaginal Cancer;   Stage IVB Vulvar Cancer;   Thyroid Gland Medullary Carcinoma;   Unresectable Extrahepatic Bile Duct Cancer;   Unresectable Gallbladder Cancer;   Urethral Cancer Associated With Invasive Bladder Cancer;   WDHA Syndrome
Interventions: Biological: recombinant interleukin-12;   Biological: ABI-007/carboplatin/trastuzumab
32 Withdrawn Study to Determine the Feasibility of Sentinel Node Biopsy in Patients With Anal Cancer
Condition: Squamous Cell Carcinoma of the Anus
Intervention: Procedure: Sentinel lymph node biopsy
33 Recruiting Phase 2 Study of ADXS11-001 in Subjects With Anal Cancer or Cancer of the Rectum
Conditions: Anal Cancer;   Rectal Cancer
Intervention: Drug: ADXS11-001
34 Recruiting Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy
Condition: Anal Carcinoma
Interventions: Radiation: Irradiation;   Drug: Mitomycin C;   Drug: 5-Fluorouracil;   Procedure: Hyperthermia
35 Active, not recruiting Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV
Conditions: Anal Cancer;   HIV Infection;   Human Papilloma Virus Infection
Interventions: Procedure: comparison of screening methods;   Other: laboratory biomarker analysis;   Other: questionnaire administration;   Procedure: quality-of-life assessment
36 Completed Image Fusion PET, CT and 3D-ultrasound Examinations
Condition: Anal Cancer
Intervention:
37 Completed Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA Test
Conditions: Anal Canal HPV Infection Diagnosis;   Anal Dysplasia Diagnosis;   Anal Cancer
Intervention: Device: HC2 collection kit with a swab or brush
38 Terminated QOL & Functional Outcomes After Combined Modality Tx for Anal CA: Comparison of Conventional vs IMRT
Condition: Anal Cancer
Intervention:
39 Withdrawn Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers
Conditions: Gastrointestinal Neoplasms;   Gynecologic Cancers;   Gynecologic Cancers Cervical Cancer;   Gastric (Stomach) Cancer;   Gastro-Esophageal(GE) Junction Cancer;   Gastrointenstinal Stromal Tumor (GIST);   Colon/Rectal Cancer;   Colon/Rectal Cancer Colon Cancer;   Colon/Rectal Cancer Rectal Cancer;   Colon/Rectal Cancer Anal Cancer;   Anal Cancer;   Hepatobiliary Cancers;   Hepatobiliary Cancers Liver;   Pancreatic Cancer
Interventions: Procedure: Blood Draw;   Procedure: Frozen Tumor Specimens
40 Completed Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
Conditions: Anal Cancer;   Colorectal Cancer;   Drug/Agent Toxicity by Tissue/Organ;   Radiation Enteritis
Interventions: Drug: octreotide acetate;   Other: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years